Market Share of Neuromyelitis Optica Spectrum Disorder Industry
The neuromyelitis optica spectrum disorder market is semi-consolidated, with many major players operating in it. Companies are focusing on adopting various business strategies such as collaborations, acquisitions, and product approvals to maintain their market position. Key players in this market include Hoffmann-La Roche Ltd, Horizon Therapeutics PLC, TG Therapeutics, Opexa Therapeutics, and Mitsubishi Tanabe Pharma.
Neuromyelitis Optica Spectrum Disorder Market Leaders
-
Hoffmann-La Roche Ltd
-
TG Therapeutics
-
Opexa Therapeutics
-
Mitsubishi Tanabe Pharma
-
Horizon Therapeutics plc (Viela Bio)
*Disclaimer: Major Players sorted in no particular order
